Almirall is looking for new assets that could be used for the treatment of skin conditions such as immune-inflammatory, dermato-oncology, and rare diseases
Almirall joins BIOMAP (Biomarkers in Atopic Dermatitis and Psoriasis) as a new partner
Almirall started research collaborations with the University of South Australia and Hospital de la Santa Creu i Sant Pau
Almirall and University of Dundee started a multi-target partnership to develop novel Targeted Protein Degraders medicines.
AlmirallShare launches its fifth call for proposals to identify new assets for the treatment of dermatological conditions